Fox Chase Cancer Center: Avapritinib Provided Greater Benefit Than Other Tyrosine Kinase Inhibitors for Mutated Gastrointestinal Stromal Tumors

Media coverage

• Title	Fox Chase Cancer Center: Avapritinib Provided Greater Benefit Than Other Tyrosine Kinase Inhibitors for Mutated Gastrointestinal Stromal Tumors
  Media name/outlet	Targeted News Service
  Country/Territory	United States
  Date	05/19/21
  Persons	Margaret von Mehren

• Title	Fox Chase Cancer Center: Avapritinib Provided Greater Benefit Than Other Tyrosine Kinase Inhibitors for Mutated Gastrointestinal Stromal Tumors
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	05/18/21
  Persons	Margaret von Mehren